ID GMIP_HUMAN Reviewed; 970 AA. AC Q9P107; A0AVN9; B7ZLZ0; DT 29-MAR-2005, integrated into UniProtKB/Swiss-Prot. DT 22-JUL-2008, sequence version 2. DT 10-FEB-2021, entry version 153. DE RecName: Full=GEM-interacting protein; DE Short=GMIP; GN Name=GMIP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH GEM. RC TISSUE=Leukemia; RX PubMed=12093360; DOI=10.1042/bj20020829; RA Aresta S., de Tand-Heim M.-F., Beranger F., de Gunzburg J.; RT "A novel Rho GTPase-activating-protein interacts with Gem, a member of the RT Ras superfamily of GTPases."; RL Biochem. J. 367:57-65(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., RA Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., RA Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., RA Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A., RA Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J., RA Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M., RA Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W., RA Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V., RA Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D., RA McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I., RA Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L., RA Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., RA She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., RA Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=16964243; DOI=10.1038/nbt1240; RA Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; RT "A probability-based approach for high-throughput protein phosphorylation RT analysis and site localization."; RL Nat. Biotechnol. 24:1285-1292(2006). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Platelet; RX PubMed=18088087; DOI=10.1021/pr0704130; RA Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J., RA Schuetz C., Walter U., Gambaryan S., Sickmann A.; RT "Phosphoproteome of resting human platelets."; RL J. Proteome Res. 7:526-534(2008). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-234 AND SER-243, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [8] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19413330; DOI=10.1021/ac9004309; RA Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.; RT "Lys-N and trypsin cover complementary parts of the phosphoproteome in a RT refined SCX-based approach."; RL Anal. Chem. 81:4493-4501(2009). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-234, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200; RA Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., RA Mann M., Daub H.; RT "Large-scale proteomics analysis of the human kinome."; RL Mol. Cell. Proteomics 8:1751-1764(2009). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-234, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [12] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21406692; DOI=10.1126/scisignal.2001570; RA Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., RA Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.; RT "System-wide temporal characterization of the proteome and phosphoproteome RT of human embryonic stem cell differentiation."; RL Sci. Signal. 4:RS3-RS3(2011). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-234; SER-437; RP SER-441; THR-660; SER-885; SER-907; SER-914; SER-919 AND SER-923, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma, and Erythroleukemia; RX PubMed=23186163; DOI=10.1021/pr300630k; RA Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., RA Mohammed S.; RT "Toward a comprehensive characterization of a human cancer cell RT phosphoproteome."; RL J. Proteome Res. 12:260-271(2013). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [15] RP X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 80-357. RG Structural genomics consortium (SGC); RT "Crystal structure of the N-terminal domain of the GEM interacting RT protein."; RL Submitted (MAR-2011) to the PDB data bank. CC -!- FUNCTION: Stimulates, in vitro and in vivo, the GTPase activity of CC RhoA. {ECO:0000269|PubMed:12093360}. CC -!- SUBUNIT: Interacts with GEM through its N-terminal. CC {ECO:0000269|PubMed:12093360}. CC -!- INTERACTION: CC Q9P107; Q92619: ARHGAP45; NbExp=3; IntAct=EBI-11603420, EBI-2825900; CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9P107-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9P107-2; Sequence=VSP_056142; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF132541; AAF61330.1; -; mRNA. DR EMBL; AC011458; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471106; EAW84839.1; -; Genomic_DNA. DR EMBL; BC126436; AAI26437.1; -; mRNA. DR EMBL; BC144142; AAI44143.1; -; mRNA. DR CCDS; CCDS12408.1; -. [Q9P107-1] DR CCDS; CCDS74318.1; -. [Q9P107-2] DR PIR; D59435; D59435. DR RefSeq; NP_001275927.1; NM_001288998.1. DR RefSeq; NP_001275928.1; NM_001288999.1. [Q9P107-2] DR RefSeq; NP_057657.2; NM_016573.3. [Q9P107-1] DR PDB; 3QWE; X-ray; 2.40 A; A=80-357. DR PDBsum; 3QWE; -. DR SMR; Q9P107; -. DR BioGRID; 119442; 8. DR IntAct; Q9P107; 9. DR STRING; 9606.ENSP00000203556; -. DR iPTMnet; Q9P107; -. DR PhosphoSitePlus; Q9P107; -. DR BioMuta; GMIP; -. DR DMDM; 212286192; -. DR EPD; Q9P107; -. DR jPOST; Q9P107; -. DR MassIVE; Q9P107; -. DR MaxQB; Q9P107; -. DR PaxDb; Q9P107; -. DR PeptideAtlas; Q9P107; -. DR PRIDE; Q9P107; -. DR ProteomicsDB; 83629; -. [Q9P107-1] DR Antibodypedia; 61622; 73 antibodies. DR Ensembl; ENST00000203556; ENSP00000203556; ENSG00000089639. [Q9P107-1] DR Ensembl; ENST00000587238; ENSP00000467054; ENSG00000089639. [Q9P107-2] DR GeneID; 51291; -. DR KEGG; hsa:51291; -. DR UCSC; uc002nnd.5; human. [Q9P107-1] DR CTD; 51291; -. DR DisGeNET; 51291; -. DR GeneCards; GMIP; -. DR HGNC; HGNC:24852; GMIP. DR HPA; ENSG00000089639; Tissue enhanced (blood, bone marrow, lymphoid tissue). DR MIM; 609694; gene. DR neXtProt; NX_Q9P107; -. DR OpenTargets; ENSG00000089639; -. DR PharmGKB; PA134963566; -. DR VEuPathDB; HostDB:ENSG00000089639.10; -. DR eggNOG; KOG1453; Eukaryota. DR GeneTree; ENSGT00950000183110; -. DR HOGENOM; CLU_006236_1_0_1; -. DR InParanoid; Q9P107; -. DR OMA; HRKCMEV; -. DR PhylomeDB; Q9P107; -. DR TreeFam; TF351450; -. DR PathwayCommons; Q9P107; -. DR Reactome; R-HSA-194840; Rho GTPase cycle. DR SIGNOR; Q9P107; -. DR BioGRID-ORCS; 51291; 11 hits in 877 CRISPR screens. DR ChiTaRS; GMIP; human. DR EvolutionaryTrace; Q9P107; -. DR GenomeRNAi; 51291; -. DR Pharos; Q9P107; Tbio. DR PRO; PR:Q9P107; -. DR Proteomes; UP000005640; Chromosome 19. DR RNAct; Q9P107; protein. DR Bgee; ENSG00000089639; Expressed in blood and 189 other tissues. DR ExpressionAtlas; Q9P107; baseline and differential. DR Genevisible; Q9P107; HS. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0005654; C:nucleoplasm; IDA:HPA. DR GO; GO:0005886; C:plasma membrane; IDA:HPA. DR GO; GO:0005096; F:GTPase activator activity; IDA:HGNC-UCL. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0090630; P:activation of GTPase activity; IBA:GO_Central. DR GO; GO:0035556; P:intracellular signal transduction; IDA:HGNC-UCL. DR GO; GO:0034260; P:negative regulation of GTPase activity; IDA:BHF-UCL. DR GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome. DR Gene3D; 1.10.555.10; -; 1. DR Gene3D; 1.20.1270.60; -; 1. DR InterPro; IPR027267; AH/BAR_dom_sf. DR InterPro; IPR031160; F_BAR. DR InterPro; IPR002219; PE/DAG-bd. DR InterPro; IPR008936; Rho_GTPase_activation_prot. DR InterPro; IPR000198; RhoGAP_dom. DR Pfam; PF00620; RhoGAP; 1. DR SMART; SM00109; C1; 1. DR SMART; SM00324; RhoGAP; 1. DR SUPFAM; SSF103657; SSF103657; 1. DR SUPFAM; SSF48350; SSF48350; 1. DR PROSITE; PS51741; F_BAR; 1. DR PROSITE; PS50238; RHOGAP; 1. DR PROSITE; PS00479; ZF_DAG_PE_1; 1. DR PROSITE; PS50081; ZF_DAG_PE_2; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Coiled coil; GTPase activation; KW Metal-binding; Phosphoprotein; Reference proteome; Zinc; Zinc-finger. FT CHAIN 1..970 FT /note="GEM-interacting protein" FT /id="PRO_0000056725" FT DOMAIN 81..344 FT /note="F-BAR" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01077" FT DOMAIN 554..757 FT /note="Rho-GAP" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00172" FT ZN_FING 493..537 FT /note="Phorbol-ester/DAG-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00226" FT COMPBIAS 252..257 FT /note="Poly-Arg" FT COMPBIAS 354..419 FT /note="Pro-rich" FT COMPBIAS 763..828 FT /note="Pro-rich" FT MOD_RES 19 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 71 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q6PGG2" FT MOD_RES 231 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:24275569" FT MOD_RES 234 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:18669648, FT ECO:0000244|PubMed:19369195, ECO:0000244|PubMed:19690332, FT ECO:0000244|PubMed:23186163" FT MOD_RES 243 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:18669648" FT MOD_RES 437 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 441 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 660 FT /note="Phosphothreonine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 885 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 907 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 914 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 919 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT MOD_RES 923 FT /note="Phosphoserine" FT /evidence="ECO:0000244|PubMed:23186163" FT VAR_SEQ 442..467 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_056142" FT VARIANT 641 FT /note="D -> N (in dbSNP:rs12003)" FT /id="VAR_044518" FT CONFLICT 666 FT /note="E -> D (in Ref. 1; AAF61330)" FT /evidence="ECO:0000305" FT CONFLICT 773 FT /note="S -> F (in Ref. 1; AAF61330)" FT /evidence="ECO:0000305" FT CONFLICT 870 FT /note="V -> C (in Ref. 1; AAF61330)" FT /evidence="ECO:0000305" FT HELIX 81..89 FT /evidence="ECO:0000244|PDB:3QWE" FT HELIX 93..140 FT /evidence="ECO:0000244|PDB:3QWE" FT HELIX 149..176 FT /evidence="ECO:0000244|PDB:3QWE" FT HELIX 178..229 FT /evidence="ECO:0000244|PDB:3QWE" FT HELIX 248..322 FT /evidence="ECO:0000244|PDB:3QWE" FT HELIX 324..335 FT /evidence="ECO:0000244|PDB:3QWE" FT TURN 336..338 FT /evidence="ECO:0000244|PDB:3QWE" FT HELIX 343..351 FT /evidence="ECO:0000244|PDB:3QWE" SQ SEQUENCE 970 AA; 106683 MW; 8163EF62F85EB2EE CRC64; MDAAEPGLPP GPEGRKRYSD IFRSLDNLEI SLGNVTLEML AGDPLLSEDP EPDKTPTATV TNEASCWSGP SPEGPVPLTG EELDLRLIRT KGGVDAALEY AKTWSRYAKE LLAWTEKRAS YELEFAKSTM KIAEAGKVSI QQQSHMPLQY IYTLFLEHDL SLGTLAMETV AQQKRDYYQP LAAKRTEIEK WRKEFKEQWM KEQKRMNEAV QALRRAQLQY VQRSEDLRAR SQGSPEDSAP QASPGPSKQQ ERRRRSREEA QAKAQEAEAL YQACVREANA RQQDLEIAKQ RIVSHVRKLV FQGDEVLRRV TLSLFGLRGA QAERGPRAFA ALAECCAPFE PGQRYQEFVR ALRPEAPPPP PPAFSFQEFL PSLNSSPLDI RKKLSGPLPP RLDENSAEPG PWEDPGTGWR WQGTPGPTPG SDVDSVGGGS ESRSLDSPTS SPGAGTRQLV KASSTGTESS DDFEERDPDL GDGLENGLGS PFGKWTLSSA AQTHQLRRLR GPAKCRECEA FMVSGTECEE CFLTCHKRCL ETLLILCGHR RLPARTPLFG VDFLQLPRDF PEEVPFVVTK CTAEIEHRAL DVQGIYRVSG SRVRVERLCQ AFENGRALVE LSGNSPHDVS SVLKRFLQEL TEPVIPFHLY DAFISLAKTL HADPGDDPGT PSPSPEVIRS LKTLLVQLPD SNYNTLRHLV AHLFRVAARF MENKMSANNL GIVFGPTLLR PPDGPRAASA IPVTCLLDSG HQAQLVEFLI VHYEQIFGMD ELPQATEPPP QDSSPAPGPL TTSSQPPPPH LDPDSQPPVL ASDPGPDPQH HSTLEQHPTA TPTEIPTPQS DQREDVAEDT KDGGGEVSSQ GPEDSLLGTQ SRGHFSRQPV KYPRGGVRPV THQLSSLALV ASKLCEETPI TSVPRGSLRG RGPSPAAASP EGSPLRRTPL PKHFEITQET ARLLSKLDSE AVPRATCCPD VQPEEAEDHL //